PJP Among Health Care ETFs
End-of-day Nov 19, 2026 · 39 Health care ETFs by Max
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.0% | −3.7% | −0.1% | −3.1% | +21.1% | +21.9% | +85.6% | +63.5% | +137.0% | +783.5% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$61 of every $1,000 in PJP is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 6.14% | $614.26 | 218K | $36.8M |
| 2 | LLYEli Lilly | Healthcare | 6.06% | $605.92 | 26K | $36.3M |
| 3 | ABBVAbbVie | Healthcare | 5.82% | $581.96 | 122K | $34.9M |
| 4 | AMGNAmgen | Healthcare | 5.42% | $541.61 | 73K | $32.5M |
| 5 | JNJJohnson & Johnson | Healthcare | 5.40% | $539.95 | 119K | $32.4M |
| 6 | PFEPfizer | Healthcare | 5.31% | $531.17 | 1.1M | $31.8M |
| 7 | ABTAbbott Laboratories | Healthcare | 4.86% | $485.85 | 279K | $29.1M |
| 8 | MRKMerck | Healthcare | 4.76% | $476.32 | 207K | $28.5M |
| 9 | AMRXAmneal Pharmaceuticals | Healthcare | 3.76% | $376.40 | 1.0M | $22.6M |
| 10 | VTRSViatris | Healthcare | 3.74% | $373.92 | 1.1M | $22.4M |
| 11 | PRGOPerrigo | Healthcare | 3.61% | $360.66 | 1.3M | $21.6M |
| 12 | BIIBBiogen | Healthcare | 3.51% | $351.05 | 84K | $21.0M |
| 13 | REGNRegeneron Pharmaceuticals | Healthcare | 3.49% | $349.48 | 22K | $20.9M |
| 14 | UTHRUnited Therapeutics | Healthcare | 3.43% | $343.16 | 36K | $20.6M |
| 15 | TARSTarsus Pharmaceuticals | Healthcare | 3.28% | $327.71 | 259K | $19.6M |
of the $111B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 6.14% |
| 2 | LLY | Eli Lilly & | 6.06% |
| 3 | ABBV | AbbVie | 5.82% |
| 4 | AMGN | Amgen | 5.42% |
| 5 | JNJ | Johnson & Johnson | 5.40% |
| 6 | PFE | Pfizer | 5.31% |
| 7 | ABT | Abbott Laboratories | 4.86% |
| 8 | MRK | Merck & | 4.76% |
| 9 | AMRX | Amneal Pharmaceuticals | 3.76% |
| 10 | VTRS | Viatris | 3.74% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.30 |
| Jun 22, 2026 | Jun 26, 2026 | $0.27 |
| Mar 23, 2026 | Mar 27, 2026 | $0.31 |
| Dec 22, 2025 | Dec 26, 2025 | $0.25 |
| Sep 22, 2025 | Sep 26, 2025 | $0.24 |
| Jun 23, 2025 | Jun 27, 2025 | $0.27 |
| Mar 24, 2025 | Mar 28, 2025 | $0.27 |
| Dec 23, 2024 | Dec 27, 2024 | $0.22 |
| Sep 23, 2024 | Sep 27, 2024 | $0.20 |
| Jun 24, 2024 | Jun 28, 2024 | $0.21 |
| Mar 18, 2024 | Mar 22, 2024 | $0.17 |
| Dec 18, 2023 | Dec 22, 2023 | $0.19 |